FDA approves first enzyme replacement therapy for rare alpha-mannosidosis

[FDA]

FDA has approved Airsupra (albuterol and budesonide) inhalation aerosol for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of asthma attacks in patients with asthma 18 years of age and older.


Baca selengkapnya di : http://www.fda.gov...